Top Statins Have Equally Low Rhabdomyolysis Risk, Says Graham In JAMA
This article was originally published in The Tan Sheet
Executive Summary
The top three statins - Zocor, Lipitor, and Pravachol -have roughly equivalent low risks of rhabdomyolysis, according to a study of health plan prescription data released by the Journal of the American Medical Association Nov. 23